WO2016101931A2 - High potency collection and processing solution for abelmoschus manihot flower crude drug - Google Patents

High potency collection and processing solution for abelmoschus manihot flower crude drug Download PDF

Info

Publication number
WO2016101931A2
WO2016101931A2 PCT/CN2016/072612 CN2016072612W WO2016101931A2 WO 2016101931 A2 WO2016101931 A2 WO 2016101931A2 CN 2016072612 W CN2016072612 W CN 2016072612W WO 2016101931 A2 WO2016101931 A2 WO 2016101931A2
Authority
WO
WIPO (PCT)
Prior art keywords
flower
okra
flowers
individual
harvesting
Prior art date
Application number
PCT/CN2016/072612
Other languages
French (fr)
Chinese (zh)
Other versions
WO2016101931A3 (en
Inventor
董文佳
李建波
李文一
杨苏睿
王建树
王亚伦
Original Assignee
王亚伦
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 王亚伦 filed Critical 王亚伦
Priority to PCT/CN2016/072612 priority Critical patent/WO2016101931A2/en
Publication of WO2016101931A2 publication Critical patent/WO2016101931A2/en
Publication of WO2016101931A3 publication Critical patent/WO2016101931A3/en

Links

Definitions

  • the invention belongs to the field of modern Chinese medicine development, and relates to a high-efficiency price disposal scheme of okra peanut medicine.
  • the okra described in the text of the present invention is encoded under the okra strip of the national standard "Chinese Plant Classification and Code" GB/T 14467-93 is 6000010003 [Abelmoschus manihot (Linn.) Medicus].
  • GB/T 14467-93 is 6000010003 [Abelmoschus manihot (Linn.) Medicus].
  • okra flowers should belong to a traditional Chinese medicine.
  • traditional Chinese medicine of flowers from large flowers such as lotus flowers, small flowers such as sweet-scented osmanthus, there are many records of the most efficient treatment options, and common use programs, such as chrysanthemum, honeysuckle related practical literature.
  • the biological characteristics of okra are far different from those of traditional Chinese medicines, which have been misunderstood in their most efficient price disposal schemes.
  • the scheme is not only the most efficient treatment, but the lowest titer.
  • the most typical disposal is as follows: the invention patent authorization notice number CN1048879C is written in the literature.
  • the main points are: the choice of individual flowers, only the corolla is selected.
  • the conditions for limiting the time of collecting flowers and collecting flowers are: first, the flowering time is limited, within 1.5 hours from 4 to 5 in the afternoon, and the second is the shape of the flower. It is the flower ovary that grows to the peanuts, the corolla separates the whole flower's organism tissue, and the third is to use the touch of the corolla and the corolla to get it, and use it to make the product.
  • the fourth is to illustrate the collection and use of the okra flowers. It is a collection of years of research, the most advanced scientific and technological achievements obtained by planting thousands of acres of okra per year. In addition, the significance of the production of science and education films by CCTV is even more self-evident.
  • the solution of the invention completely abandons the above-mentioned "scientific and technological achievements” scheme, and the high-price price of the raw medicine flower is quite original flower, and the potency component has no loss, the flavor is fragrant, and the taste is good.
  • the invention is directed to the treatment of the biological characteristics of the individual raw flower, and the prior art does not involve this. From the standard to the practical point of view, the invention is far from the technical improvement scheme, and the raw medicine obtained in the implementation is There is no isolated fresh flower ratio, and the potency active substance contains more than 24 types of bioflavonoids, 19 more than the actual examples in the background art, and 36 kinds of active ingredients are detected.
  • the invention provides a scheme for high-efficiency price collection, disposal and putting-in time limit of okra peanut medicine, which is characterized in that: the raw medicine for harvesting the target is selected from the limited time limit of the morphology and biological development of the okra, from the limitation of the harvesting operation.
  • the raw medicine for harvesting the target is selected from the limited time limit of the morphology and biological development of the okra, from the limitation of the harvesting operation.
  • the okra flower biological tissue before the yellowing discoloration is the subject of selection and harvesting.
  • the form of the target is the flower stalk.
  • the flower bud, the corolla, the stamen, the ovary, and the pistil are closely combined into one biological tissue; when the individual flower is harvested separately, the flower stalk tissue from the base of the flower stalk and the base of the flower bud is disconnected from the body; When harvesting flowers, the flower branches are disconnected from the base of the best individual flower buds in the open state; the above-mentioned isolated okra peanuts are put into use within 28 hours under normal temperature conditions, and the above-mentioned isolated okra flowers are used.
  • the time limit for putting it into use is less than 7 days.
  • the above-mentioned isolated okra peanut medicine is used for freezing treatment, and after thawing, the time limit for putting into use is within 9 hours.
  • the above-mentioned okra opens the flower buds and buds, which means that the stalks of the flowers of the flower buds develop from the closed form to the open form, and the yellow flower tissue state is present at 8-12 cm in front of the tip of the flower bud.
  • the above individual flower harvesting means that the individual flowers are separated from the branches and branches of the main branches or main branches of the okra ecological plant.
  • the above-mentioned flower collection is the branch of the main stem or main branch of the original eco-plant of the okra.
  • the flowers are more than two, and the branches are taken to pick the okra flower. This is different from the ornamental flower cutting. Take, just close to the lower part of the open flower, and the lower part of it can not be separated; the best individual flower in the open state of the flower branch means that the individual flower has the largest opening of the crown, and its color must also be One hour before the yellowing discoloration.
  • the above-mentioned okra flower is open and yellow, which means that the corolla is closed for 1 hour before the color change.
  • the yellowing is the fresh primary color of the flower, and the discoloration is the light brown or light cyan or light red of the corolla.
  • the flower stalk tissue from the base of the flower stalk and the base of the flower bud is dissected from the body, and the selection of the detachment point in this limited biological tissue site is random, and the flower of the okra plant is caused by the difference of region and climate.
  • the leaves and branches are in different state of occlusion, so they can only be used according to the convenience of specific operations.
  • the specific scheme of breaking off can be used by cutting instruments. The fingers are separated.
  • the okra peanut medicine disposed in the solution of the present invention has 36 kinds of active ingredients in the component processing after directly processing into a Chinese herbal medicine piece, wherein the bioflavonoid component reaches 24 kinds: 36 monomer compounds are separated therefrom, and the chemical is utilized.
  • the refrigerated treatment is put into use within 7 days, and after thawing by the freezing treatment, it is put into use for 3 hours.
  • the above two uses are respectively for the refrigerated okra flower, the defrosted okra flower is subjected to chipping refining and drying and dehydration to obtain a piece of cake, and the product effect is almost the same as that of the product directly put into operation by the ecological flower.

Abstract

The present invention relates to the field of modern Chinese traditional medicine development and relates to a high potency processing solution for Abelmoschus manihot flower crude drug. The present invention is a processing solution designed taking into account the biological characteristics of individual crude drug flower, which is absent in prior art. Viewed from standardization and practicality, the present invention is far beyond any modified technical solutions. No detached live flower can compare to the crude drug obtained from the embodiments, as the potency active substance contains no less than 24 types of bioflavonoids, 19 types more than embodiments of the prior art, and contains 36 types of active ingredients detected in tests. Frozen Abelmoschus manihot flowers are thawed, crushed, pulverized, and ground into slurry, then dried and dehydrated, and made into medicinal slices. The effect of the product is almost identical to the effect of the product made by directly using live flower in real time in the operation.

Description

高效价秋葵花生药采收处置方案High-priced okra peanut medicine harvesting and disposal plan 技术领域Technical field
本发明属于现代中药开发领域,涉及一种秋葵花生药的高效价处置方案。The invention belongs to the field of modern Chinese medicine development, and relates to a high-efficiency price disposal scheme of okra peanut medicine.
背景技术Background technique
本发明文案所述的秋葵,在国家标准《中国植物分类与代码》GB/T14467-93的秋葵属条下的编码是6000010003[Abelmoschus manihot(Linn.)Medicus]。在中药经典中,见诸1995年上海科学技术出版社出版的《中药大辞典》2075页4252、4254号辞目。The okra described in the text of the present invention is encoded under the okra strip of the national standard "Chinese Plant Classification and Code" GB/T 14467-93 is 6000010003 [Abelmoschus manihot (Linn.) Medicus]. In the classics of traditional Chinese medicine, see the repertoire of 2075 pages 4252 and 4254 published in the Dictionary of Traditional Chinese Medicine published by Shanghai Science and Technology Press in 1995.
按常规和经典著述记载,秋葵鲜花应属于一种传统中药生药范畴。在花类中药生药中,从大型花如荷花,小型花如桂花,对其最高效价的处置方案多有记载,和通行使用方案,如菊花、金银花的相关实用文献等。但秋葵花在生物学特性上,远远不同于已通用的那些中药生药花,在对其最高效价处置方案上,一直陷入误区,其方案不但是非最高效价的处置,反是最低效价的处置,最典型如:发明专利授权公告号CN1048879C文献中所写,只采用使用秋葵花的花冠,计算它的提取物效价成分及对生药的提取比例,该专利对生药处置后的效价成分含量,还不到原生态生药的30%。国内某大型药企集团,花高价购买该专利,并在此基础上,再行申报专利实施,同样按其专利方案计算,该专利采集的使用的生药黄酮种类,仅相当常规文献报道的20%。再比如:According to conventional and classic writings, okra flowers should belong to a traditional Chinese medicine. In the traditional Chinese medicine of flowers, from large flowers such as lotus flowers, small flowers such as sweet-scented osmanthus, there are many records of the most efficient treatment options, and common use programs, such as chrysanthemum, honeysuckle related practical literature. However, the biological characteristics of okra are far different from those of traditional Chinese medicines, which have been misunderstood in their most efficient price disposal schemes. The scheme is not only the most efficient treatment, but the lowest titer. The most typical disposal is as follows: the invention patent authorization notice number CN1048879C is written in the literature. Only the corolla using the okra flower is used to calculate the extract valence component and the extraction ratio of the crude drug. The valence of the patent after the disposal of the crude drug The content of ingredients is less than 30% of the original ecological drugs. A large domestic pharmaceutical enterprise group purchased the patent at a high price, and on this basis, the patent application was re-applied. According to its patent plan, the type of crude flavonoids used in the patent was only 20% of the reported in the conventional literature. . Another example:
中国中央电视台第七频道,2014年12月5日《科技苑》20141205期专题节目,“采花大王靠花生财”,用30分钟时长的视频介绍了,对秋葵生药花的采集使用。其要点有:个体花的选择,只选取花冠,在对采集花限定、采集花处置的时限的条件是,一是采花时间限定,下午4点到5点的1.5小时内,二是花的形态是花子房发育到花生米大,花冠分离出整个花的有机体组织,三是用触动花冠,花冠落手而得,用其制得产品,四是说明这种对秋葵鲜花的采集和使用方案是集数年研究,每年种植数千亩秋葵花所得来的最先进科技成果。此外,由中央电视台专题制作科教片的意义,更是不言自明。Channel 7 of China Central Television, December 5, 2014, "Science and Technology Court" 20141205 special program, "Picking the Flower King by Peanuts", introduced with a 30-minute video, the collection of okra raw medicine flowers. The main points are: the choice of individual flowers, only the corolla is selected. The conditions for limiting the time of collecting flowers and collecting flowers are: first, the flowering time is limited, within 1.5 hours from 4 to 5 in the afternoon, and the second is the shape of the flower. It is the flower ovary that grows to the peanuts, the corolla separates the whole flower's organism tissue, and the third is to use the touch of the corolla and the corolla to get it, and use it to make the product. The fourth is to illustrate the collection and use of the okra flowers. It is a collection of years of research, the most advanced scientific and technological achievements obtained by planting thousands of acres of okra per year. In addition, the significance of the production of science and education films by CCTV is even more self-evident.
植物生物学常识告诉我们,作为植物花的花冠功效是什么不言而喻,作为植物性器官的子房,花蕊是表达不同植物花功效成分的核心要件,几乎在所有中药花生药的采集使用中,均是把选择带子房、花蕊的生药花组织作为必不可少的条件。而上述秋葵生药花的采集使用却违背了基本的生物学常识,好像买椟还珠一样,来实施和推崇“科技成果”,其效果是,所采生药制品,无一点该药应有的气味和口感,性状和口感如棉絮,效价成分丧失80%以上。 The common sense of plant biology tells us that the corolla effect as a plant flower is self-evident. As an ovary of a plant organ, the flower core is the core element for expressing the functional components of different plant flowers, almost in the collection and use of all Chinese medicine peanut drugs. It is an indispensable condition for selecting the raw medicinal flower tissue with ovary and stamen. The collection and use of the above-mentioned okra raw medicinal flowers violates the basic biological common sense. It seems to buy and praise the "scientific and technological achievements", and the effect is that the raw medicine products are taken, and there is no such thing as the medicine. Odor and mouthfeel, traits and mouthfeel such as cotton wool, the potency component is lost more than 80%.
本发明方案,完全弃去上述“科技成果”方案,生药花的高效价相当原生态花,效价成分几无损失,味香,性状口感好。The solution of the invention completely abandons the above-mentioned "scientific and technological achievements" scheme, and the high-price price of the raw medicine flower is quite original flower, and the potency component has no loss, the flavor is fragrant, and the taste is good.
发明内容Summary of the invention
本发明是针对个体生药花的生物学特征来做处置的方案,已知技术中还没有涉及这一点,从标准性到实用上看,本发明远非技术改进方案可比,在实施中所得生药与没有离体的鲜活花比,效价活性物质所含生物黄酮种类在24种以上,比背景技术中现实例多19种,其活性成分的检测中有36种。The invention is directed to the treatment of the biological characteristics of the individual raw flower, and the prior art does not involve this. From the standard to the practical point of view, the invention is far from the technical improvement scheme, and the raw medicine obtained in the implementation is There is no isolated fresh flower ratio, and the potency active substance contains more than 24 types of bioflavonoids, 19 more than the actual examples in the background art, and 36 kinds of active ingredients are detected.
本发明是提供一种秋葵花生药高效价采收处置和投入使用时限的方案,其特征是:从秋葵花形态和生物学发育的限定时限上选择采收标的生药,从采收操作的限定上保障生药的稳定效价;秋葵开启花萼吐蕾后3-59小时以内或秋葵花开放后,退黄变色前的秋葵花生物组织是选择采收的标的物,此标的物的形态是花柄、花萼、花冠、雄蕊、子房、雌蕊紧密有机结合为一体的生物组织;分别做个体花采收时,从花柄基部和花萼基部这段花柄组织,做离体断开处置;做一枝群花采收时,从花枝开放状态最好的个体花花柄基部,对花枝条做离体断开处置;上述离体秋葵花生药,在常温条件下28小时内投入使用,上述离体秋葵花生药,在做冷藏处置时,投入使用的时限是7天以内。The invention provides a scheme for high-efficiency price collection, disposal and putting-in time limit of okra peanut medicine, which is characterized in that: the raw medicine for harvesting the target is selected from the limited time limit of the morphology and biological development of the okra, from the limitation of the harvesting operation. To ensure the stable potency of the crude drug; after the okra opens the flowering buds within 3.59 hours or after the opening of the okra flower, the okra flower biological tissue before the yellowing discoloration is the subject of selection and harvesting. The form of the target is the flower stalk. The flower bud, the corolla, the stamen, the ovary, and the pistil are closely combined into one biological tissue; when the individual flower is harvested separately, the flower stalk tissue from the base of the flower stalk and the base of the flower bud is disconnected from the body; When harvesting flowers, the flower branches are disconnected from the base of the best individual flower buds in the open state; the above-mentioned isolated okra peanuts are put into use within 28 hours under normal temperature conditions, and the above-mentioned isolated okra flowers are used. For crude medicine, when it is refrigerated, the time limit for putting it into use is less than 7 days.
上述离体秋葵花生药,在做冷冻处置时,解冻后,投入使用的时限是9小时以内。The above-mentioned isolated okra peanut medicine is used for freezing treatment, and after thawing, the time limit for putting into use is within 9 hours.
上述秋葵开启花萼吐蕾,是指花萼部所生花的萼片从闭合形态发育到开启形态,在花萼片尖前部8-12cm处,呈现黄色的花组织的状态。The above-mentioned okra opens the flower buds and buds, which means that the stalks of the flowers of the flower buds develop from the closed form to the open form, and the yellow flower tissue state is present at 8-12 cm in front of the tip of the flower bud.
上述个体花采收,是指单独的花朵从秋葵生态植物的主干枝或主干枝所生分枝枝干上断离分摘下来。The above individual flower harvesting means that the individual flowers are separated from the branches and branches of the main branches or main branches of the okra ecological plant.
上述一枝群花采收,是秋葵原生态植物主干枝或主干枝所生分枝上,所开花朵在二朵以上,采用断离该枝条来摘取秋葵花,这个不同于对观赏花割取,只是紧贴开放花下部断离,而其下部各点,是不能选择断离;花枝开放状态最好的个体花,是指个体花的形态花冠张开幅度最大者,其颜色也必需是退黄变色前1小时者。The above-mentioned flower collection is the branch of the main stem or main branch of the original eco-plant of the okra. The flowers are more than two, and the branches are taken to pick the okra flower. This is different from the ornamental flower cutting. Take, just close to the lower part of the open flower, and the lower part of it can not be separated; the best individual flower in the open state of the flower branch means that the individual flower has the largest opening of the crown, and its color must also be One hour before the yellowing discoloration.
上述秋葵花开放后退黄变色,是指花冠闭合变色前1小时的状态,退黄是花的鲜嫩原色减退,变色是花冠呈现隐约的浅褐色或浅青色或浅红色。The above-mentioned okra flower is open and yellow, which means that the corolla is closed for 1 hour before the color change. The yellowing is the fresh primary color of the flower, and the discoloration is the light brown or light cyan or light red of the corolla.
上述方案处置的生药花用途,是直接食用或直接做中药材产品。The use of raw medicine flowers disposed by the above scheme is to directly consume or directly make Chinese herbal medicine products.
上述从花柄基部和花萼基部这段花柄组织,做离体断开处置,其断离点在这个限定的生物组织部位的选择是随机的,因地域和气候不同,致使秋葵植物的花、叶、枝的相互遮挡状态不一,所以仅依具体操作的方便即可;断离的具体方案,可用剪切器具,可直接用人 工手指掐离。The flower stalk tissue from the base of the flower stalk and the base of the flower bud is dissected from the body, and the selection of the detachment point in this limited biological tissue site is random, and the flower of the okra plant is caused by the difference of region and climate. The leaves and branches are in different state of occlusion, so they can only be used according to the convenience of specific operations. The specific scheme of breaking off can be used by cutting instruments. The fingers are separated.
上述秋葵花退黄变色的判断,具体到地域、气候、生长季节、盛花期不同,在时间选择上,差异极大,实践中是在种植秋葵花的一个具体方位上,一个时间段上,相对有差异规律,靠用放大镜对当地、当时生育秋葵花观察几天得出,但像技术背景“科技苑”视频所展示的地域季节,在那个采花段前2小时,就可停止观察,因为自那时起的时段和视频中所讲的具体采花方案一样,对本发明来说,没有任何意义。The above-mentioned okra flower yellowing discoloration judgment, specific to the region, climate, growing season, full flowering period, in the choice of time, the difference is great, in practice is in the specific orientation of planting okra, a period of time, relative There are differences in the law, relying on a magnifying glass to observe the local, at that time, the observation of the okra flower, but the regional season shown in the video of the technical background "Technology Court", in the 2 hours before the flowering section, you can stop observing, because The time period from then on is the same as the specific flowering scheme described in the video, and does not make any sense to the present invention.
本发明方案的处置的秋葵花生药,在直接加工成中药材饮片后的成分检测中,活性成分达36种,其中生物黄酮类成分达24种:从中分离得到36个单体化合物,并利用化学方法和多种波谱技术(1HNMR、13CNMR、EI-MS、ESI-MS、HSQC、HMBC、1H-1HCOSY)等鉴定了其中30个化合物的化学结构,分别为:α-菠甾醇、豆甾醇、β-谷甾醇、β-胡萝卜苷、咖啡酸、6-甲氧基-7-羟基香豆素、十六碳酸、二十六碳酸、槲皮素、槲皮素-3’-O-葡萄糖苷、金丝桃苷、槲皮素-3-O-β-D-葡萄糖苷、棉皮素-3’-0-β-D-葡萄糖苷、3-0-咖啡酰奎尼酸、杨梅素、5-羟基-3’,4’,7,8-四甲氧基黄酮、3’,5-二羟基-7,8-三甲氧基黄酮、棉皮素、没食子酸、3’,5-二羟基-7,8-二甲氧基黄酮-4’-0-β-D-葡萄糖苷、4’,5,7,8四甲氧基黄酮、杨梅素-3-0-β-D-葡萄糖苷、槲皮素-3-0-β-D-洋槐糖苷、槲皮素-3-0-β-D-芸香糖苷、4’-甲氧基-5,7-二羟基黄酮-[0-β-D木糖-(1→3)]-0-β-D葡萄糖苷、4’,7-二甲氧基-5,7-二羟基黄酮-[-0-β-D-木糖-(1→2)]-O-β-D-葡萄糖苷、3,5-二-0-咖啡酰奎尼酸、4,5-二-0-咖啡酰奎尼酸、3,4-二-0-咖啡酰奎尼酸(29)和5-羟基-4’,7,8-三甲氧基黄酮。The okra peanut medicine disposed in the solution of the present invention has 36 kinds of active ingredients in the component processing after directly processing into a Chinese herbal medicine piece, wherein the bioflavonoid component reaches 24 kinds: 36 monomer compounds are separated therefrom, and the chemical is utilized. Methods and various spectral techniques ( 1 H NMR, 13 C NMR, EI-MS, ESI-MS, HSQC, HMBC, 1 H- 1 HCOSY) identified the chemical structures of 30 compounds, namely: α-pineol, Stigmasterol, β-sitosterol, β-carotene, caffeic acid, 6-methoxy-7-hydroxycoumarin, hexadecanoic acid, 26 carbonic acid, quercetin, quercetin-3'-O - glucoside, hyperoside, quercetin-3-O-β-D-glucoside, cotton phlecein-3'-0-β-D-glucoside, 3-0-caffeoyl quinic acid, Myricetin, 5-hydroxy-3',4',7,8-tetramethoxyflavone, 3',5-dihydroxy-7,8-trimethoxyflavone, linseed, gallic acid, 3', 5-dihydroxy-7,8-dimethoxyflavone-4'-0-β-D-glucoside, 4',5,7,8 tetramethoxyflavone, myricetin-3-0-β- D-glucoside, quercetin-3-0-β-D-inoside, quercetin-3-0-β-D-rutinoside, 4'-methoxy-5,7-dihydroxy Flavonoids-[0-β-D xylose-(1→3)]-0-β-D glucoside, 4',7-dimethoxy-5,7-dihydroxyflavone-[-0-β- D-xylose-(1→2)]-O-β-D-glucoside, 3,5-di-0-caffeoylquinic acid, 4,5-di-O-caffeoylquinic acid, 3 4-di-O-caffeoylquinic acid (29) and 5-hydroxy-4',7,8-trimethoxyflavone.
实施例1Example 1
北京通州种植10亩秋葵,时当8月中旬,正值秋葵花盛花期。科技部中国技术交易所一副总裁介绍一药企曹总经理,实地考察秋葵花生药处置,发明人团队2人陪同实地实践。事前,经一周时间观察,知在当月气候下,当地所种秋葵花每天退黄变色的时间,类同背景技术中所提的采花时间,即下午4-5点钟。通州种植地每天的花开状态,是花萼吐蕾后的多种状态。次日,上午11时,曹总经理带车并二人,发明人团队二人,共同赶到通州秋葵种植地进行个体花的断离采收,一是选择花萼吐蕾后30小时的秋葵花,二是选择距离下午4、5点钟5小时前的11时开放的花,所断离采收花形态是花柄、花萼、花冠、雄蕊、子房、雌蕊紧密有机结合为一体的生物组织,不用手工、机械之力、用力撕裂剥离不能分开各组织。采收时用手工从上述所选花的花柄以上,花萼基部断离个体花,收得个体花300朵。然后再常温送到北四环中科院植物所一化验室检测分析,其效价的标志性生物黄酮种类金丝桃苷的含量,按干品计,均在1.18%以上,高于国家标准1倍还多。 Beijing Tongzhou planted 10 acres of okra, when mid-August, is the okra flower bloom period. A vice president of the China Technology Exchange of the Ministry of Science and Technology introduced a general manager of a pharmaceutical company Cao, on-site inspection of okra peanut drug disposal, and the inventor team accompanied two people on the ground. Beforehand, after a week of observation, it is known that in the current month's climate, the time of the local okra flower to turn yellow and discoloration every day is similar to the picking time mentioned in the background art, that is, 4-5 o'clock in the afternoon. The flowering state of the Tongzhou planting area is a variety of states after the flower buds. The next day, at 11 o'clock in the morning, General Manager Cao took the car and two people, two inventors team, rushed to the Tongzhou Okra planting site to separate the individual flowers, one is to choose the 30-hour autumn after the flower buds Sunflower, the second is to choose the flower that is open at 11 o'clock in the afternoon at 4 and 5 o'clock in the afternoon. The flower shape is the combination of flower stalk, flower bud, corolla, stamen, ovary and pistil. Tissue, without manual, mechanical force, force tearing and peeling can not separate the tissues. At the time of harvesting, the flower buds were separated from the individual flower by the hand above the flower stalk of the selected flower, and 300 individual flowers were collected. Then, it is sent to the laboratory of the Institute of Botany, Chinese Academy of Sciences, North Fourth Ring for testing and analysis. The content of the iconic bioflavonoids, hypericin, is more than 1.18%, which is 1 times higher than the national standard. Still more.
实施例2Example 2
中国农科院国际产业化基地,一块秋葵研发种植地所生长秋葵,面临当年霜降季节,仍有秋葵开花,据最近12天观察,当时花的退黄变色是在第二天的上午11时,更现实的是,此事气候变冷快,秋葵枝条上的多个吐蕾花,很可能遇冷受害,于是决定从枝条上断离收花,于是决定周日早上8时开始采收,收得枝条花后,在常温下送生化所贮藏备用,采收冷藏一部分,冷冻一部分,冷藏处置的7天内投入使用,冷冻处置的解冻后,3小时投入使用。上述两种使用是分别对冷藏秋葵花,解冻秋葵花进行碎裂磨浆和干燥脱水制得饮片操作,制品效果与直接采用生态花即时投入操作的产品几无差异。 The International Industrialization Base of the Chinese Academy of Agricultural Sciences, an okra that grows in the planting area of the okra, faces the autumn of the year, and there is still okra flowering. According to the recent 12 days of observation, the yellowing discoloration of the flower was in the morning of the next day. At 1100, it is more realistic that the climate is getting colder and faster. Many of the bud flowers on the okra branches are likely to suffer from cold damage. So I decided to break the flowers from the branches, so I decided to start at 8 am on Sunday. After harvesting, the branches of flowers are collected and stored at room temperature for storage at the biochemical reserve. A part of the refrigerated storage is taken, and a part of the refrigerator is frozen. The refrigerated treatment is put into use within 7 days, and after thawing by the freezing treatment, it is put into use for 3 hours. The above two uses are respectively for the refrigerated okra flower, the defrosted okra flower is subjected to chipping refining and drying and dehydration to obtain a piece of cake, and the product effect is almost the same as that of the product directly put into operation by the ecological flower.

Claims (7)

  1. 本发明是提供一种秋葵花生药高效价采收处置和投入使用时限的方案,其特征是:从秋葵花形态和生物学发育的限定时限上选择采收标的生药,从采收操作的限定上保障生药的稳定效价;秋葵开启花萼吐蕾后3-59小时以内或秋葵花开放后,退黄变色前的秋葵花生物组织是选择采收的标的物,此标的物的形态是花柄、花萼、花冠、雄蕊、子房、雌蕊紧密有机结合为一体的生物组织;分别做个体花采收时,从花柄基部和花萼基部这段花柄组织,做离体断开处置;做一枝群花采收时,从花枝开放状态最好的个体花花柄基部,对花枝条做离体断开处置;上述离体秋葵花生药,在常温条件下28小时内投入使用,上述离体秋葵花生药,在做冷藏处置时,投入使用的时限是7天以内。The invention provides a scheme for high-efficiency price collection, disposal and putting-in time limit of okra peanut medicine, which is characterized in that: the raw medicine for harvesting the target is selected from the limited time limit of the morphology and biological development of the okra, from the limitation of the harvesting operation. To ensure the stable potency of the crude drug; after the okra opens the flowering buds within 3.59 hours or after the opening of the okra flower, the okra flower biological tissue before the yellowing discoloration is the subject of selection and harvesting. The form of the target is the flower stalk. The flower bud, the corolla, the stamen, the ovary, and the pistil are closely combined into one biological tissue; when the individual flower is harvested separately, the flower stalk tissue from the base of the flower stalk and the base of the flower bud is disconnected from the body; When harvesting flowers, the flower branches are disconnected from the base of the best individual flower buds in the open state; the above-mentioned isolated okra peanuts are put into use within 28 hours under normal temperature conditions, and the above-mentioned isolated okra flowers are used. For crude medicine, when it is refrigerated, the time limit for putting it into use is less than 7 days.
  2. 权利要求1所述离体秋葵花生药,在做冷冻处置时,解冻后,投入使用的时限是9小时以内。The isolated okra peanut medicine according to claim 1, wherein the time limit for putting it into use after thawing is less than 9 hours.
  3. 权利要求1所述秋葵开启花萼吐蕾,是指花萼部所生花的萼片从闭合形态发育到开启形态,在花萼片尖前部8-12cm处,呈现黄色的花组织的状态。The okra opening flower buds and buds according to claim 1 means that the stalks of the flowers of the flower buds develop from a closed form to an open form, and a yellow flower tissue state is present at 8-12 cm in front of the apex of the bud.
  4. 权利要求1所述个体花采收,是指单独的花朵从秋葵生态植物的主干枝或主干枝所生分枝枝干上断离分摘下来。The individual flower harvesting according to claim 1, wherein the individual flowers are separated from the branch branches of the main branch or the main branch of the okra ecological plant.
  5. 权利要求1所述上述一枝群花采收,是秋葵原生态植物主干枝或主干枝所生分枝上,所开花朵在二朵以上,采用断离该枝条来摘取秋葵花,这个不同于对观赏花割取,只是紧贴开放花下部断离,而其下部各点,是不能选择断离;花枝开放状态最好的个体花,是指个体花的形态花冠张开幅度最大者,其颜色也必需是退黄变色前1小时者。The above-mentioned flower collection of claim 1 is the branch of the main branch of the okra original ecological plant or the branches of the main branch, and the flowers are more than two, and the branch is taken to pick the okra flower. In the cutting of ornamental flowers, it is only close to the lower part of the open flower, and the lower part of the flower can not be separated; the best individual flower in the open state of the flower branch refers to the largest opening of the individual flower. The color must also be one hour before the yellowing discoloration.
  6. 权利要求1所述秋葵花开放后退黄变色,是指花冠闭合变色前1小时的状态,退黄是花的鲜嫩原色减退,变色是花冠呈现隐约的浅褐色或浅青色或浅红色。The yellowing discoloration of the okra flower according to claim 1 refers to a state in which the corolla is closed for 1 hour before discoloration, and the yellowing is a decrease in the fresh primary color of the flower, and the discoloration is a pale brown or light cyan or light red in the corolla.
  7. 权利要求1所述上述方案处置的生药花用途,是直接食用或直接做中药材产品。 The use of the raw medicinal flower disposed by the above-mentioned solution according to claim 1 is a direct consumption or direct use of a Chinese medicinal material.
PCT/CN2016/072612 2016-01-28 2016-01-28 High potency collection and processing solution for abelmoschus manihot flower crude drug WO2016101931A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2016/072612 WO2016101931A2 (en) 2016-01-28 2016-01-28 High potency collection and processing solution for abelmoschus manihot flower crude drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2016/072612 WO2016101931A2 (en) 2016-01-28 2016-01-28 High potency collection and processing solution for abelmoschus manihot flower crude drug

Publications (2)

Publication Number Publication Date
WO2016101931A2 true WO2016101931A2 (en) 2016-06-30
WO2016101931A3 WO2016101931A3 (en) 2016-11-03

Family

ID=56151559

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/072612 WO2016101931A2 (en) 2016-01-28 2016-01-28 High potency collection and processing solution for abelmoschus manihot flower crude drug

Country Status (1)

Country Link
WO (1) WO2016101931A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111990063A (en) * 2020-08-03 2020-11-27 中国农业科学院油料作物研究所 Efficient and mechanized sesame combined harvesting method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1319543C (en) * 2001-05-08 2007-06-06 王绍璋 Wild hibiscus Chinese medicine material and herbal pieces
CN1408202B (en) * 2001-09-21 2012-06-27 王绍璋 Recovery and storage method of fresh and live wild lotus and application thereof
CN1292678C (en) * 2003-02-26 2007-01-03 王立 Sunflower vegetables
US20100303995A1 (en) * 2007-10-22 2010-12-02 Beijing Dongsheng Agricultural Technology Development (Group) Co., Ltd. Natural nutritional supplementary food of abelmoschus manihot (linn.) medius
CN103271954A (en) * 2013-05-22 2013-09-04 杭州求本植物科技有限公司 Flavoniodes processing technology
CN105746096A (en) * 2014-12-19 2016-07-13 王亚伦 High-potency gumbo flower crude drug harvesting and disposal scheme

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111990063A (en) * 2020-08-03 2020-11-27 中国农业科学院油料作物研究所 Efficient and mechanized sesame combined harvesting method

Also Published As

Publication number Publication date
WO2016101931A3 (en) 2016-11-03

Similar Documents

Publication Publication Date Title
Szakiel et al. Influence of environmental abiotic factors on the content of saponins in plants
KR20120003317A (en) Composition for inhibiting the degranulation of mast cell comprising plant extracts
Srivastava An updated review on phyto-pharmacological and pharmacognostical profile of Amaranthus tricolor: A herb of nutraceutical potentials
Potter Cannabis horticulture
Jeeva Horticultural potential of wild edible fruits used by the Khasi tribes of Meghalaya
Rao et al. Establishment of two varieties in tecoma stans of Indian origin pharmacognostically and pharmacologically
WO2016101931A2 (en) High potency collection and processing solution for abelmoschus manihot flower crude drug
Zeipiņa et al. Antioxidant activity in nettle (Urtica dioica L.) and garden orache (Atriplex hortensis L.) leaves during vegetation period
Takle et al. Pharmacognostic and Phytochemical investigations of aerial parts of Acalypha indica Linn.
Bisht et al. Distribution and indigenous uses of some medicinal plants in district Uttarkashi, Uttarakhand, India
Akbar Hussain et al. Sources of betalains
CN105746096A (en) High-potency gumbo flower crude drug harvesting and disposal scheme
CN102125061B (en) Pesticide for killing aphid and red spider and preparation method thereof
Abdalaziz et al. In vitro antioxidant activity and phytochemical screening of Croton zambesicus
KR20120105403A (en) Composition for inhibiting the degranulation of mast cell comprising plant extracts
Alaye et al. Evaluation of pytochemicals and vitamins constituents of Corchorus aestuans L.
Idrees et al. Frangipani
Chwil et al. Nectar production and pollen yield of Echium vulgare L. in the climatic conditions of Lublin
Sarjadi et al. TOTAL FLAVONOID CONTENT AND ANTIOXIDANT ACTIVITYBY DIFFERENT DRYING AND EXTRACTION METHODS OF Clinacanthus nutans LEAVES
Toma et al. Morphological and anatomical study of Psidium guajava Linn.(guava)-a new fruit tree and medicinal plant researched in Romania.
Kalita et al. Arisaema Jacquemontii Blume, Jacquemont’s Cobra Lily
Mitra et al. A mini review on phytochemical and therapeutic potentiality of Hibiscus: An ornamental plant species
Bh et al. PHARMACOGNOSY OF SOUTH INDIAN DATEPALM–PHOENIX PUSILLA
Lim Hylocereus undatus
Shrivastava et al. Dactylorhiza Hatagirea (D. Don) Soo: Himalayan Marsh Orchid

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16730999

Country of ref document: EP

Kind code of ref document: A2